Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase NA 3Phase 3 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1 2Phase 4 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1Genitourinary 1Breast 1

Conditions

Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1Neoplasms 1Hypogonadism 1Hot Flashes 1Fatigue 1Breast Neoplasms 1Arthralgia 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Testosterone × Clear all
NCT04833426 2025-05-02

ENFORCE

Canisius-Wilhelmina Hospital

Phase 3 Recruiting
140 enrolled
Genitourinary

Hypogonadism, Prostatic Neoplasms

NCT01573442 2025-01-28

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

Alliance for Clinical Trials in Oncology

Phase 3 Completed
227 enrolled 22 charts
BreastOther

Breast Neoplasms, Sexual Dysfunction, Physiological, Arthralgia, Hot Flashes

NCT00965341 2016-09-13

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
53 enrolled 8 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡